Menu
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€1.27

€1.27

3.830%
0.048
3.830%
-
 
11.08.26 / Tradegate WKN: A1J09L / Symbol: STXS / Name: Stereotaxis / Stock / Healthcare Equipment & Supplies / Micro Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction

Stereotaxis Stock

Stereotaxis dominated the market today, gaining €0.048 (3.830%).
Our community identified positive and negative aspects for Stereotaxis stock for the coming years. 0 users see the criterium "Worthwhile Investment for the next years" as a plus for the Stereotaxis stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.

Pros and Cons of Stereotaxis in the next few years

Pros
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Cons
?
S********** s********
?
B****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Stereotaxis vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Stereotaxis 3.830% 3.758% -9.929% -45.726% -35.204% -11.189% -79.180%
Cardiff Oncology Inc. -1.640% -3.650% 7.221% -60.215% -66.873% -54.810% -83.370%
Electrocore Inc. 5.660% 54.128% 63.107% 96.262% 119.895% 129.101% -34.280%
Lightpath Techs A 16.670% 15.929% 31.658% - 46.369% - -

News

Stereotaxis Q2 Earnings Call HighlightsPhoto, wide shot, wide-angle lens,  Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png
Stereotaxis Q2 Earnings Call Highlights

Key Points

Stereotaxis Q1 Earnings Call HighlightsPhoto, wide shot, wide-angle lens,  Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png
Stereotaxis Q1 Earnings Call Highlights

Stereotaxis (NYSEAMERICAN:STXS) said its first-quarter results did not yet reflect what management described as a major commercial transition